-Tissue Procurement and Biospecimens Processing (TPFB) Shared Resource The mission of the Tissue Procurement and Biospecimens Processing Shared Resource (TPFB) is to support and enhance cancer-related translational, clinical, population and basic science research. This is achieved by providing UNC Lineberger Comprehensive Cancer Center members with a centralized, coordinated, quality- controlled, quality-assured facility for the procurement, processing, storage, and distribution of biologic specimens. The facility procures biologic specimens for biobanking purposes utilizing its own IRB-approved protocols. In addition, the facility now serves over 75 investigator-initiated IRB approved protocols, with both blood and tissue being collected Additional services include consultation on biospecimen collection issues, execution of pilot studies, assay development, and help with grant and publication submissions. The facility is staffed with experienced personnel with over 30 years of combined tissue procurement, biospecimen processing, nucleic acid extraction, and biorepository lab experience. The TPFB shared resource has a long- term relationship with the Department of Surgical Pathology, such that most requests for research tissues are routed through the core to insure that each project has undergone the appropriate IRB review. This has resulted in a smooth and seamless centralized collection process for the banking of solid tissues, both fresh and frozen, and blood products. All aspects of sample processing are tracked from the time the technician is paged to retrieve the sample to arrival in the lab, through all processing steps, storage location, and ending with distribution. In the last funding period, the tumor procurement and biospecimen processing efforts of the facility resulted in over 60 high impact cancer-related publications. The total operating budget of the facility is $1,001,303 of which we are requesting $299,303 from the CCSG. The previous budget $891,328 for which CCSG support was 22% resulted in >200,000 specimens collected from 3600 unique cancer patients.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016086-44
Application #
9834860
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2019-12-01
Budget End
2020-11-30
Support Year
44
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Brock, William J; Beaudoin, James J; Slizgi, Jason R et al. (2018) Bile Acids as Potential Biomarkers to Assess Liver Impairment in Polycystic Kidney Disease. Int J Toxicol 37:144-154
Thomas, Nancy E; Edmiston, Sharon N; Tsai, Yihsuan S et al. (2018) Utility of TERT Promoter Mutations for Cutaneous Primary Melanoma Diagnosis. Am J Dermatopathol :
Bensen, Jeannette T; Graff, Mariaelisa; Young, Kristin L et al. (2018) A survey of microRNA single nucleotide polymorphisms identifies novel breast cancer susceptibility loci in a case-control, population-based study of African-American women. Breast Cancer Res 20:45
Hall, Marissa G; Marteau, Theresa M; Sunstein, Cass R et al. (2018) Public support for pictorial warnings on cigarette packs: an experimental study of US smokers. J Behav Med 41:398-405
Ma, Shaohua; Paiboonrungruan, Chorlada; Yan, Tiansheng et al. (2018) Targeted therapy of esophageal squamous cell carcinoma: the NRF2 signaling pathway as target. Ann N Y Acad Sci 1434:164-172
Aung, Kyaw L; Fischer, Sandra E; Denroche, Robert E et al. (2018) Genomics-Driven Precision Medicine for Advanced Pancreatic Cancer: Early Results from the COMPASS Trial. Clin Cancer Res 24:1344-1354
Suh, Junghyun L; Watts, Brian; Stuckey, Jacob I et al. (2018) Quantitative Characterization of Bivalent Probes for a Dual Bromodomain Protein, Transcription Initiation Factor TFIID Subunit 1. Biochemistry 57:2140-2149
Myung, Ja Hye; Eblan, Michael J; Caster, Joseph M et al. (2018) Multivalent Binding and Biomimetic Cell Rolling Improves the Sensitivity and Specificity of Circulating Tumor Cell Capture. Clin Cancer Res 24:2539-2547
Lindström, Linda S; Yau, Christina; Czene, Kamila et al. (2018) Intratumor Heterogeneity of the Estrogen Receptor and the Long-term Risk of Fatal Breast Cancer. J Natl Cancer Inst 110:726-733
Jayasinghe, Reyka G; Cao, Song; Gao, Qingsong et al. (2018) Systematic Analysis of Splice-Site-Creating Mutations in Cancer. Cell Rep 23:270-281.e3

Showing the most recent 10 out of 1525 publications